Article ID Journal Published Year Pages File Type
8829704 Urological Science 2017 6 Pages PDF
Abstract
Our study demonstrated that Lipodox can enhance doxorubicin cytotoxicity in bladder cancer cells and inhibit tumor growth in orthotopic bladder cancer with improved survival rate. Therefore, we suggest Lipodox may act as an alternative to doxorubicin in the treatment of local bladder cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Urology
Preview
Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer
Authors
, , , ,